Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Mechanical strain using 2D and 3D bioreactors induces osteogenesis: implications for bone tissue engineering.

van Griensven M., Diederichs S., Roeker S., Boehm S., Peterbauer A., Wolbank S.

Laboratory Study, published in Adv Biochem Eng Biotechnol (2009) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Adv Biochem Eng Biotechnol (2009)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
19290499
DOI
10.1007/978-3-540-69357-4_5

Abstract (original English)

Fracture healing is a complicated process involving many growth factors, cells, and physical forces. In cases, where natural healing is not able, efforts have to be undertaken to improve healing. For this purpose, tissue engineering may be an option. In order to stimulate cells to form a bone tissue several factors are needed: cells, scaffold, and growth factors. Stem cells derived from bone marrow or adipose tissues are the most useful in this regard. The differentiation of the cells can be accelerated using mechanical stimulation. The first part of this chapter describes the influence of longitudinal strain application. The second part uses a sophisticated approach with stem cells on a newly developed biomaterial (Sponceram) in a rotating bed bioreactor with the administration of bone morphogenetic protein-2. It is shown that such an approach is able to produce bone tissue constructs. This may lead to production of larger constructs that can be used in clinical applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Biomechanical PhenomenaBioreactorsBone Marrow CellsBone Morphogenetic Protein 2Bone and BonesCell DifferentiationEquipment DesignHumansIntercellular Signaling Peptides and ProteinsMechanotransduction, Cellular

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.